Intranasal dry powders are gaining attention as a promising alternative for drug delivery—offering a non-invasive route with the potential to expand how biologics and other therapies are administered.
In this podcast episode, based on an expert-led webinar, we explore the science and formulation strategy behind intranasal dry powders, and how recent advances are helping overcome long-standing development challenges. You’ll hear how optimized spray-drying approaches enable precise control over particle size, improved yield, and powders designed to meet both clinical and commercial requirements.
The discussion also connects nasal delivery to lessons learned from oral inhalation—covering topics such as shelf stability, dose flexibility, delivery efficiency, and ease of use—and what this means for the future of nasal formulations.
Whether you’re working in drug product development, CMC, or respiratory drug delivery, this podcast offers practical insights into formulation, scale-up, and characterization of nasal powders, helping you stay informed on an evolving area of drug delivery science.
Listen to the podcast to deepen your understanding of intranasal dry powder development and where the field is heading.
